Created on 03.26
The full safety assessment report for VeYol BDO is freshly released!
Good news! Guangdong Qingda Zhixing Biotechnology Co., Ltd. has achieved positive results! The safety tests commissioned by the company on its flagship product, VeYol BDO, by Guangzhou Jinzhi Testing Technology Co., Ltd. have been successfully completed with ideal outcomes. These tests include the 28-Day Repeated Dose Oral Toxicity Test, Ultraviolet Absorption Characteristics Test, and In Vitro Mammalian Cell Chromosome Aberration Test.
Combined with the safety assessment report on VeYol BDO issued by Shanghai Intertek Testing Services Co., Ltd. last year, it can be concluded that Qingda’s VeYol BDO now possesses complete safety assessment data and meets the latest national regulatory requirements. Customers can use this product with complete confidence.
According to the report, when used at a concentration below 17.6%, VeYol BDO is considered not to pose a hazard to human health under intended, normal and foreseeable conditions of use.
Previously, skin patch tests had been conducted on VeYol BDO. The results showed that aqueous solutions of 10% and 15% VeYol BDO were non-irritating to the skin.Its milder nature allows for a reduction in the amount of anti-irritant ingredients used in formulations.
Whether through skin patch tests or the completion of a full safety assessment report, the goal is to provide customers with safe, reliable, regulatory-compliant, and high-quality VeYol BDO for assured use.
电话
WhatsAPP